Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
STIM

STIM - Neuronetics, Inc Stock Price, Fair Value and News

$2.12-0.12 (-5.36%)
Market Closed

58/100

STIM

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

58/100

STIM

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.32

Target 3M

$2.18

Target 6M

$2.22

STIM Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

STIM Price Action

Last 7 days

6.5%

Last 30 days

53.6%

Last 90 days

-21.5%

Trailing 12 Months

-29.6%

STIM RSI Chart

STIM Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

STIM Valuation

Market Cap

145.2M

Price/Earnings (Trailing)

-3.28

Price/Sales (Trailing)

1.12

Price/Free Cashflow

-4.86

STIM Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.32

Target 3M

$2.18

Target 6M

$2.22

STIM Fundamentals

STIM Revenue

Revenue (TTM)

129.9M

Rev. Growth (Yr)

101.28%

Rev. Growth (Qtr)

-2.13%

STIM Earnings

Earnings (TTM)

-44.2M

Earnings Growth (Yr)

32.2%

Earnings Growth (Qtr)

8.07%

STIM Profitability

Operating Margin

77.59%

Return on Equity

-161.7%

Return on Assets

-30.41%

Free Cashflow Yield

-20.59%

STIM Investor Care

Shares Dilution (1Y)

125.67%

Diluted EPS (TTM)

-0.83

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202589.4M111.1M129.9M0
202471.3M70.1M71.3M74.9M
202366.6M67.8M68.7M69.4M
202257.2M59.3M62.0M65.2M
202150.1M54.5M55.9M55.3M
202061.4M54.6M51.0M49.2M
201955.4M58.7M60.9M62.7M
201843.1M46.0M49.2M52.8M
201735.8M37.3M38.9M40.4M
201600034.2M
Get all data in R, Python etc through our Historical Stock Data APIs

About Neuronetics, Inc

STIM
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
 CEO
 WEBSITEhttps://neurostar.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES209

Neuronetics, Inc Frequently Asked Questions

STIM is the stock ticker symbol of Neuronetics, Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Neuronetics, Inc is 145.19 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check STIM's fair value in chart for subscribers.

The fair value guage provides a quick view whether STIM is over valued or under valued. Whether Neuronetics, Inc is cheap or expensive depends on the assumptions which impact Neuronetics, Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STIM.

As of Wed Jan 28 2026, STIM's PE ratio (Price to Earnings) is -3.28 and Price to Sales (PS) ratio is 1.12. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STIM PE ratio will change depending on the future growth rate expectations of investors.